Severe kidney disease can be problematic because kidneys must process detoxification byproducts
However, as with any trendy product, its crucial to delve into the potential risks associated with its usage
With prolonged or high-dose use, receptors may become less responsive, making the peptide less effective
Obesity, insulin resistance and fatty liver may further amplify this cycle by increasing inflammatory signaling, altering bile-acid metabolism and reducing metabolic reserve
Before starting treatment, your provider will review or order: BMI and blood pressure measurement, fasting blood glucose or A1C, lipid profile, kidney and liver function, hormone levels if indicated by your history, and body composition analysis
Graphical Abstract Similar content being viewed by others The discovery of glucagon The discovery of insulin in 1921 by Banting et al [1] was paralleled by the observation that pancreatic extracts [2] and crude insulin preparations [3] induce a brief hyperglycaemic episode before glucose levels decrease below baseline